Neocis Guidance System (NGS) with Patient Splints
FDA 510(k)Class II (US FDA 510(k))
by Neocis Inc
Identifiers
- 510(k) Number
- K200805 FDA 510(k)
- FDA Product Code
- PLV FDA 510(k)
Classification
- Device Class
- Class II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 872.4120 FDA 510(k)
- Regulation Number
- 872.4120 FDA 510(k)
- Advisory Committee
- Dental FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
The Neocis Guidance System (NGS) with Patient Splints is a Dental Stereotaxic Instrument intended to provide assistance in both the planning (pre-operative) and the surgical (in-operative) phases of dental procedures. It is a computerized navigational system designed to support accurate instrument guidance during oral and maxillofacial surgery.
The device is supplied as a reusable system with patient-specific splints, intended for use in clinical dental settings. It is classified as a Class II medical device under FDA regulation 872.4120, with product code PLV, and received traditional 510(k) clearance (K200805) on July 28, 2020, based on substantial equivalence to a predicate device.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Neocis Guidance System (NGS) with Patient Splints (K200805) — FDA 510 ..., Neocis Guidance System (NGS) with Patient Splints… - FDA.report, K200805 FDA 510(k) - Neocis Guidance System (NGS) with Patie...
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_510K
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | K200805 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Neocis Inc
- FDA Applicant
- Neocis, Inc.
Sources (1)
- FDA 510(k) K200805 24 fields · synced Sep 22, 2026